ESC Premium Access

Low-dose rivaroxaban during the acute phase of ACS - H-REPLACE Trial)

Congress Session

About the speaker

Professor Shenghua Zhou

The Second Xiangya Hospital of Central South University, Changsha (China)
1 presentation
0 follower

3 more presentations in this session

QUORUM : Quantum Genomics Firibastat (QGC001) or Ramipril after Acute Myocardial Infarction for Prevention of Left Ventricular Dysfunction

Speaker: Professor G. Montalescot (Paris, FR)

Thumbnail

HUYGENS: Evolocumab and changes in plaque composition on OCT

Speaker: Professor S. Nicholls (Melbourne, AU)

Thumbnail

ACCOST-HH: Adrecizumab in cardiogenic shock

Speaker: Doctor M. Karakas (Hamburg, DE)

Thumbnail

Access the full session

Late Breaking Trials in ACS

Speakers: Professor S. Zhou, Professor G. Montalescot, Professor S. Nicholls, Doctor M. Karakas
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

The Day in Focus - Sunday 29 August - Panel.

29 August 2021

Open Access

Patient selection for Temporary Mechanical Circulatory Support: who benefits the most?

29 August 2021

This platform is supported by

logo Novo Nordisk